Delivery Order SPE2DB22D2007-SPE2DB25FJ1SJ

Award Date 5/21/25
Potential Completion Date 6/12/25
Potential Value $15K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of OPDIVO 240 MG/24 ML VIAL 24ML, a pharmaceutical product, with a ceiling value of $61,029.25. The contract is a firm fixed-price, non-set-aside delivery order with a period of performance through May 27, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of OPDIVO 240 MG/24 ML VIAL 24ML. The contract has a total ceiling value of $7,647.40 and an ultimate completion date of October 7, 2024. It is a firm fixed-price contract and does not have any set-aside designations. Amerisourcebergen, through its Corporate Office division, will be responsible for delivering these pharmaceutical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OPDIVO 100 MG/10 ML VIAL 10ML, a pharmaceutical product, with a ceiling value of $12,386.52 and a performance period through June 2, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Opdivo, a 240 mg/24 ml vial medication, with a ceiling value of $40,418.81 and a performance period that runs through June 4, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of OPDIVO 240 MG/24 ML VIAL 24ML. The contract is a Firm Fixed Price delivery order with a ceiling value of $30,589.60 and a period of performance through August 28, 2024. This contract award is not associated with a set-aside designation. As a key supplier of pharmaceutical products and medical supplies to the U.S. federal government,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $59,627.16, is for the delivery of OPDIVO 240 MG/24 ML VIAL 24ML, a specialty medication. The contract has a period of performance through April 1, 2025 and is a firm fixed-price contract. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $14,906.79, is for the supply of OPDIVO 240 MG/24 ML VIAL 24ML, a prescription medication. The delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,128.84, is for the supply of OPDIVO 100 MG/10 ML VIAL 10ML, a pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of April 2, 2025. It is not designated as a set-aside contract. AmerisourceBergen holds a larger Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $61,115.70 and is for the delivery of OPDIVO 240 MG/24 ML VIAL 24ML, a specialty medication. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Opdivo, a specialty cancer medication. The contract is a firm-fixed-price delivery order with a ceiling value of $9,937.86 and a period of performance through May 29, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB25FJ1SJ
    Delivery Order

This is a delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of OPDIVO 240 MG/24 ML VIAL 24ML. The contract has a ceiling value of $14,906.79 and is a firm fixed-price delivery order, with an ultimate completion date of June 12, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 8/20/25, 9:52 AM